This event has been organised and facilitated by Heidelberg Engineering and is also sponsored by Santen and Medisoft. It will contain information about Santen products.
This website is intended for UK healthcare professionals only.
Webinar: Glaucoma in 2020
Thursday 14th May 2020
7:00pm – 8:00pm
The cancellation of ophthalmic congresses worldwide leaves a chasm in communication between eye care professionals in 2020. Heidelberg Engineering has teamed up with Santen and Medisoft to provide a platform for clinicians specialising in glaucoma to present their latest research and other topics of interest to the ophthalmic community.

The live interactive webinar “Glaucoma in 2020” will take place on Thursday 14th May 2020 at 7:00-8:00pm. It will be chaired by Professor Gus Gazzard, Director of Glaucoma Service, Moorfields Eye Hospital, and will feature presentations from four eminent eye care professionals.


Welcome and introduction:
Professor Gus Gazzard, Consultant Ophthalmic Surgeon, Moorfields Eye Hospital

Disaster mitigation- saving Sight in the Climate of COVID-19:
Mr. Faisal Ahmed, Consultant Ophthalmic Surgeon, Imperial College NHS Trust, UK

Can we do visual fields in our armchairs?:
Professor David Crabb, Professor of Statistics and Vision Research, City University London

Glaucoma Treatment Paradigms in the post-COVID-19 post-LiGHT era:
Professor Gus Gazzard, Consultant Ophthalmic Surgeon, Moorfields Eye Hospital

Optimising therapeutic management: insights from real world evidence:
Dr. Francesco Oddone MD, PhD, Head of the Glaucoma Unit, Britannic Hospital of the IRCCS Fondazione Bietti, Rome, Italy

Question and Answer Session


Professor Gus Gazzard MD MA(Cantab) MBBChir FRCOphth


Gus Gazzard completed undergraduate and medical school training at Corpus Christi College, Cambridge University. He was made a Consultant in the Glaucoma Service at Moorfields Eye Hospital in 2009 after a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw in Singapore 1999-2002, where he ran and established several clinical trials investigating the surgical treatments of glaucoma (including the Singapore-5FU and ACLIPS trials, both published in Ophthalmology).

In 2019 he was appointed a UCL Professor of Ophthalmology (Glaucoma Studies) at the Institute of Ophthalmology, University College London and is currently Director of the Glaucoma service at Moorfields.

Gus’ has an interest in the drop-free treatments of glaucoma with current research into selective laser trabeculoplasty (SLT) and Minimally Invasive Glaucoma procedures (‘MIGS’). He is training surgeons in the use of the iStent, Preserflo / InnFocus MicroShunt and Hydrus devices. Gus has established two large, 6-year studies of laser treatment in the UK and China and is co-ordinating a number of Cochrane Collaboration Reports and defining outcomes for Minimally Invasive Glaucoma Surgical devices.

In 2012 he established, as Chief Investigator, the 6-year NIHR-HTA funded (£2m) multi-centre LiGHT trial of selective laser trabeculoplasty which completed recruitment of 718 subjects on target, on-time and is published in The Lancet 2019. He has since raised over £500k to support this and other projects. The sister trial, LiGHT-China, recently finished enrolment of 769 subjects in collaboration with Sun Yat Sen University, Guangzhou.

Gus’ clinical research interests include angle closure glaucoma, selective laser trabeculoplasty, randomised controlled trials of glaucoma treatments and anterior segment imaging. He collaborated on the TAGS trial of surgery for advanced glaucoma; was a member of the EAGLE Study Group (an international multi-centre study of early lens extraction in angle-closure); on the advisory board for the ZAP trial (assessing preventative laser iridotomy); co-founder of the European Glaucoma Society Special Interest Group in Angle Closure, contributor to the EGS Glaucoma Treatment Guidelines, co-chair of the EGS external-relations committee and currently working on the Royal College of Ophthalmologists Angle Closure Guidelines.

He sits on the awards panels of the BCPB (British Campaign to Prevent Blindness) and the International Glaucoma Association and is a Trustee of the Friends of Moorfields Charity.

Mr Faisal Ahmed, MBBS, BSc (Hons) FRCOPHTH (UK),Consultant Ophthalmic Surgeon


Faisal Ahmed is a senior Glaucoma Ophthalmic Consultant Surgeon at Imperial College Healthcare NHS Trust and Honorary Senior Lecturer at Imperial College, London.

He was a trainee and glaucoma research fellow at Moorfields Eye Hospital and undertook a clinical glaucoma fellowship at the Western Eye Hospital.

Faisal is a longstanding volunteer for Humanity First a UK registered Humanitarian Charity. He set up the medical supplies department as well as the Medical Disaster Response course and lead author of the original course manual, upon which the UK government ran its first medical disaster response course as well.

Mr Ahmed was the UK national coordinator for World Glaucoma Day. He is a keen surgical trainer and publishes regularly on new surgical techniques.
Faisal has a special interest in minimally invasive glaucoma surgery (MIGS) and is one of the authors for the Emerging Laser and Surgical Treatments for Glaucoma national website which is an award winning website and is the standard for all Royal College trainees.

Faisal was part of a team that won a national award for development of an electronic patient record system and is currently IT lead for Imperial Ophthalmology.

Professor David Crabb, MSc, PhD, Professor of Statistics and Vision Research


David Crabb is Professor of Statistics and Vision Research at City, University of London. He gained degrees in Mathematics and Statistics at Oxford and Sheffield before completing a PhD in Visual Science in 1996. Following a post-doctoral position at University College London, and a lectureship in Nottingham, he returned to City in 2005 and was made professor in 2010. Professor Crabb’s research laboratory (@CrabbLab), contains a lively mixture of optometrists, vision scientists, ophthalmologists, psychologists, mathematicians and computer scientists. This research laboratory focuses on measurement in vision: visual fields, imaging and imaging processing, visual function, eye movements and electrophysiology. The Crabb Lab also uses “big data” from NHS clinics to investigate health service delivery of age-related eye disease. Another main theme of his work is relating the different stages in age-related eye disease to patient’s vision related quality of life.

Dr. Francesco Oddone MD, PhD


Dr. Francesco Oddone is the Head of the Glaucoma Unit at the Britannic Hospital of the IRCCS Fondazione Bietti in Rome (Italy) where he coordinates a team of basic science researchers and clinicians engaged in the study of the underlining mechanisms of the disease as well in clinical research activities including diagnostic, surgical and pharmacological research, clinical trials and systematic reviews. He is member of the executive commettee of the Italian Association for the Study of Glaucoma (AISG) and of the Italian Perimetry and Imaging Society (SIPe). He is also member of the Special Interest Group “Next Generation Partnership” and of the Glaucoma Guidelines Committee of the European Glaucoma Society (EGS), and member of the Glaucoma Expert Committee of the He currently acts as the Italian Delegate at the European Board of Ophthalmology (EBO) and at the European Union of Medical Specialists (UEMS).

He was speaker at more than 500 national and international meetings around the world and authored several book chapters and more than 100 peer-reviewed international scientific publications.


Job code: PP-SANTEN-UK-0018
May 2020